Stephanie Bouchard
The Obama administration announced Tuesday that it will invest $156 million over two years to fight Alzheimer's disease and its ripple effects.
The Measures Application Partnership (MAP) has submitted its recommendations on the improvement and coordination of care by post-acute care and long-term care providers to the U.S. Department of Health and Human Services (HHS).
The U.S. Department of Health and Human Services needs to strengthen its oversight capacity, according to the Office of Inspector General's annual summary of management and performance challenges facing the agency.
Job growth in the healthcare sector will outpace other sectors through 2020 predicts new statistics released by the U.S. Bureau of Labor Statistics.
The panel of physicians that makes recommendations to the Centers for Medicare & Medicaid Services about the relative value of physician services has voted to add two new members to its current roster of 29.
The aging of the country's population and the rise in healthcare costs will continue to be the nation's biggest economic challenge concluded the Congressional Budget Office's latest economic outlook, released Tuesday.
A new study finds that state legislated caps on mandatory overtime of nurses' work hours work as intended but the study's authors say the need for legislating such caps would be moot if facility leaders were progressive in their thinking about handling nurse scheduling.
Anecdotally, it is believed within the healthcare community that doctors are leaving Medicare in greater and greater numbers. A new report by the Office of Inspector General has found that there is not enough data available to make any determinations about this trend.
The healthcare industry is making progress but is being held back by a broken political structure, said American College of Physicians leadership Thursday in a live web broadcast reviewing its State of the Nation's Health Care report.
India's largest drug manufacturer, Ranbaxy Laboratories and its U.S. subsidiary, Ranbaxy Inc., and the U.S. Justice Department, and U.S. Food and Drug Administration have reached an agreement over allegations that the company was selling potentially unsafe drugs in the United States.